Report Detail
Global Meningococcal Vaccine Market Insights, Forecast to 2025
- RnM2983296 |
- 19 February, 2019 |
- Global |
- 114 Pages |
- QYResearch |
- Pharma & Healthcare
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
Top-down and bottom-up approaches are used to validate the global Meningococcal Vaccinesize market and estimate the market size for manufacturers, regions segments, product segments and applications.
The market estimations in this report are based on the marketed sale price of Meningococcal Vaccine. The percentage splits, Market Share, and breakdowns of the product segments are derived on the basis of weightages assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Meningococcal Vaccine market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major players in the market are identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top manufacturers; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, Market Share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYR Pharma & Healthcare Research Center and presented in this report.
The global Meningococcal Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Meningococcal Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Meningococcal Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Meningococcal Vaccine in these regions.
This research report categorizes the global Meningococcal Vaccine market by top players/brands, region, type and end user. This report also studies the global Meningococcal Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
Market size by Product
Quadrivalent
Bivalent
Others
Market size by End User
Pneumonia
Meningitis
Bacteremia
Others (Arthritis, Conjunctivitis, Urethritis)
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Meningococcal Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Meningococcal Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Meningococcal Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Meningococcal Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Meningococcal Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Dose). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Meningococcal Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Meningococcal Vaccine Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Meningococcal Vaccine Market Size Growth Rate by Product
- 1.4.2 Quadrivalent
- 1.4.3 Bivalent
- 1.4.4 Others
- 1.5 Market by End User
- 1.5.1 Global Meningococcal Vaccine Market Size Growth Rate by End User
- 1.5.2 Pneumonia
- 1.5.3 Meningitis
- 1.5.4 Bacteremia
- 1.5.5 Others (Arthritis, Conjunctivitis, Urethritis)
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Meningococcal Vaccine Market Size
- 2.1.1 Global Meningococcal Vaccine Revenue 2014-2025
- 2.1.2 Global Meningococcal Vaccine Sales 2014-2025
- 2.2 Meningococcal Vaccine Growth Rate by Regions
- 2.2.1 Global Meningococcal Vaccine Sales by Regions
- 2.2.2 Global Meningococcal Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Meningococcal Vaccine Sales by Manufacturers
- 3.1.1 Meningococcal Vaccine Sales by Manufacturers
- 3.1.2 Meningococcal Vaccine Sales Market Share by Manufacturers
- 3.1.3 Global Meningococcal Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.2 Meningococcal Vaccine Revenue by Manufacturers
- 3.2.1 Meningococcal Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Meningococcal Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.3 Meningococcal Vaccine Price by Manufacturers
- 3.4 Meningococcal Vaccine Manufacturing Base Distribution, Product Types
- 3.4.1 Meningococcal Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Meningococcal Vaccine Product Type
- 3.4.3 Date of International Manufacturers Enter into Meningococcal Vaccine Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Meningococcal Vaccine Sales by Product
- 4.2 Global Meningococcal Vaccine Revenue by Product
- 4.3 Meningococcal Vaccine Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Meningococcal Vaccine Breakdown Data by End User
6 North America
- 6.1 North America Meningococcal Vaccine by Countries
- 6.1.1 North America Meningococcal Vaccine Sales by Countries
- 6.1.2 North America Meningococcal Vaccine Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Meningococcal Vaccine by Product
- 6.3 North America Meningococcal Vaccine by End User
7 Europe
- 7.1 Europe Meningococcal Vaccine by Countries
- 7.1.1 Europe Meningococcal Vaccine Sales by Countries
- 7.1.2 Europe Meningococcal Vaccine Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Meningococcal Vaccine by Product
- 7.3 Europe Meningococcal Vaccine by End User
8 Asia Pacific
- 8.1 Asia Pacific Meningococcal Vaccine by Countries
- 8.1.1 Asia Pacific Meningococcal Vaccine Sales by Countries
- 8.1.2 Asia Pacific Meningococcal Vaccine Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Meningococcal Vaccine by Product
- 8.3 Asia Pacific Meningococcal Vaccine by End User
9 Central & South America
- 9.1 Central & South America Meningococcal Vaccine by Countries
- 9.1.1 Central & South America Meningococcal Vaccine Sales by Countries
- 9.1.2 Central & South America Meningococcal Vaccine Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Meningococcal Vaccine by Product
- 9.3 Central & South America Meningococcal Vaccine by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Meningococcal Vaccine by Countries
- 10.1.1 Middle East and Africa Meningococcal Vaccine Sales by Countries
- 10.1.2 Middle East and Africa Meningococcal Vaccine Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Meningococcal Vaccine by Product
- 10.3 Middle East and Africa Meningococcal Vaccine by End User
11 Company Profiles
- 11.1 Novartis
- 11.1.1 Novartis Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Novartis Meningococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Novartis Meningococcal Vaccine Products Offered
- 11.1.5 Novartis Recent Development
- 11.2 GSK
- 11.2.1 GSK Company Details
- 11.2.2 Company Business Overview
- 11.2.3 GSK Meningococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 GSK Meningococcal Vaccine Products Offered
- 11.2.5 GSK Recent Development
- 11.3 Merck
- 11.3.1 Merck Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Merck Meningococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Merck Meningococcal Vaccine Products Offered
- 11.3.5 Merck Recent Development
- 11.4 CSL
- 11.4.1 CSL Company Details
- 11.4.2 Company Business Overview
- 11.4.3 CSL Meningococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 CSL Meningococcal Vaccine Products Offered
- 11.4.5 CSL Recent Development
- 11.5 Baxter
- 11.5.1 Baxter Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Baxter Meningococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Baxter Meningococcal Vaccine Products Offered
- 11.5.5 Baxter Recent Development
- 11.6 JN International Medical Corporation
- 11.6.1 JN International Medical Corporation Company Details
- 11.6.2 Company Business Overview
- 11.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 JN International Medical Corporation Meningococcal Vaccine Products Offered
- 11.6.5 JN International Medical Corporation Recent Development
- 11.7 Serum Institute of India
- 11.7.1 Serum Institute of India Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Serum Institute of India Meningococcal Vaccine Products Offered
- 11.7.5 Serum Institute of India Recent Development
- 11.8 Bio-Med
- 11.8.1 Bio-Med Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Bio-Med Meningococcal Vaccine Products Offered
- 11.8.5 Bio-Med Recent Development
- 11.9 China National Biotec Group
- 11.9.1 China National Biotec Group Company Details
- 11.9.2 Company Business Overview
- 11.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 China National Biotec Group Meningococcal Vaccine Products Offered
- 11.9.5 China National Biotec Group Recent Development
- 11.10 Hualan Bio
- 11.10.1 Hualan Bio Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Hualan Bio Meningococcal Vaccine Products Offered
- 11.10.5 Hualan Bio Recent Development
- 11.11 Walvax
- 11.12 Zhifei
12 Future Forecast
- 12.1 Meningococcal Vaccine Market Forecast by Regions
- 12.1.1 Global Meningococcal Vaccine Sales Forecast by Regions 2019-2025
- 12.1.2 Global Meningococcal Vaccine Revenue Forecast by Regions 2019-2025
- 12.2 Meningococcal Vaccine Market Forecast by Product
- 12.2.1 Global Meningococcal Vaccine Sales Forecast by Product 2019-2025
- 12.2.2 Global Meningococcal Vaccine Revenue Forecast by Product 2019-2025
- 12.3 Meningococcal Vaccine Market Forecast by End User
- 12.4 North America Meningococcal Vaccine Forecast
- 12.5 Europe Meningococcal Vaccine Forecast
- 12.6 Asia Pacific Meningococcal Vaccine Forecast
- 12.7 Central & South America Meningococcal Vaccine Forecast
- 12.8 Middle East and Africa Meningococcal Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Meningococcal Vaccine Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Meningococcal Vaccine . Industry analysis & Market Report on Meningococcal Vaccine is a syndicated market report, published as Global Meningococcal Vaccine Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Meningococcal Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
